Anti-Infective Drugs Advisory Committee
Meeting on November 3, 2011, from 8 a.m. to 5 p.m. (Day 1 of 2)
Agenda: On November 3, 2011, the committee will discuss clinical trial design issues for the development of antibacterials for the treatment of community-acquired bacterial pneumonia and the draft document entitled ‘‘Guidance for Industry: Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment,’’ published March 2009 (see FDA Web site at http://www.fda.gov/ Drugs/GuidanceCompliance RegulatoryInformation/Guidances/ ucm064980.htm)
Monday, October 3, 2011
Subscribe to:
Post Comments (Atom)


No comments:
Post a Comment